|
Novavax News is an EIN News Service for health professionals. Constantly updated news and information about health.
- StockProfiler.US: Stock Watch: PRXL, NVAX, VRNM 2 Nov 2009 18:37 GMT
... COMTEX) -- PAREXEL International Corporation (NASDAQ: PRXL); Novavax, Inc. (NASDAQ: NVAX); Verenium Corporation (NASDAQ: VRNM) ... across the development and commercialization continuum, from drug development and regulatory consulting to clinical pharmacology, ... integrated, end-to-end capabilities and cutting-edge technology in pre-treatment, novel enzyme development, fermentation and project development ...
- NOVAVAX to Present at Oppenheimer 20th Annual Healthcare Conference 2 Nov 2009 21:33 GMT
... NOVAVAX to Present at Oppenheimer 20th Annual Healthcare ... who are leaders and pioneers in the pharmaceutical, biotechnology, medical device, healthcare facility, health technology ... as health reform, Medicare and Medicaid, generic drug regulation, development of new blockbuster pharmaceutical and biotechnology ...
- Wall Street News Alert: Trade Alert: AEN, HGSI, NVAX 2 Nov 2009 14:36 GMT
... Human Genome Sciences, Inc. (NASDAQ: HGSI) and Novavax, Inc. (NASDAQ: NVAX). Adeona Pharmaceuticals, Inc. (AMEX: ... dedicated to the awareness, diagnosis, prevention and treatment of zinc deficiency and chronic toxicity in ... also developing a number of late-stage clinical drug candidates for the treatment of rheumatoid arthritis ...
- Novavax Reports Positive Data for its Trivalent Seasonal Influenza (VLP) Vaccine Candidate in a Second Phase II Study 2 Nov 2009 13:31 GMT
... ROCKVILLE, Md., Nov. 2 /PRNewswire-FirstCall/ -- Novavax, Inc. (Nasdaq: NVAX) a clinical-stage vaccine company, announced ... portable, recombinant cell-culture technology. is a clinical-stage biotechnology company, creating novel vaccines to address a ... recently launched a joint venture with Cadila Pharmaceuticals, named CPL Biologicals, to develop and manufacture ...
- BiomedReports: News and FDA Updates for Covidien (NYSE:COV), Alnylam (Nasdaq:ALNY), Novavax (Nasdaq:NVAX), Geron (Nasdaq:GERN) 2 Nov 2009 12:37 GMT
... Mallinckrodt Inc., has received U.S. Food and Drug Administration (FDA) approval of its Abbreviated New ... the U.S. financial markets close. On 10/30/09, Novavax, Inc. (Nasdaq:NVAX) announced it will report its ... stem cell (hESC)-based product, GRNOPC1, for the treatment of spinal cord injury. Biotech investors interested ...
- Novavax Reports Third Quarter 2009 Financial Results 6 Nov 2009 13:36 GMT
... of the Private Securities Litigation Reform Act. Novavax cautions that these forward-looking statements are subject ... pilot plant facility is subject to standard FDA inspections, which may result in increased costs ... for clinical resources and patient enrollment from drug candidates in development by other companies with greater ...
- Novavax Announces Poster Presentation at the 47th Annual Meeting of the IDSA 2 Nov 2009 19:50 GMT
... Novavax Announces Poster Presentation at the 47th Annual ... pathogens, such as MRSA, Clostridium difficle, and drug-resistant mycobacteria, gram-negative bacillia and fungi; and the ... has formed a joint venture with Cadila Pharmaceuticals, named CPL Biologicals, to develop and manufacture ...
- Novavax logs more losses 6 Nov 2009 16:33 GMT
... it continues to lose money. The Rockville-based biotechnology company reports a third quarter net loss ... as it lowered expenses, including job cuts. Novavax ended the quarter with $34.4 million in the ... also launched a joint venture with a pharmaceutical company in India with construction of a ...
- Novavax seasonal flu vaccine meets study goal 2 Nov 2009 15:37 GMT
... Monday, November 2, 2009 at 7:00 AM Novavax seasonal flu vaccine meets study goal Biotechnology company Novavax Inc. said Monday its seasonal ... met key goals in a midstage clinical trial. Biotechnology company Novavax Inc. said Monday its ...
- Trading Outlook for Novavax Inc. Issued by InvestorSoup.com 4 Nov 2009 12:10 GMT
... -- InvestorSoup.com announces an investment report featuring Novavax Inc. (Nasdaq: ). The report includes financial, comparative ... should be of particular interest to other biotechnology companies: Novartis AG (NYSE: ) and Teva Pharmaceutical Industries Ltd. (Nasdaq: Get our alerts BEFORE ...
- Trading Outlook for Novavax Inc. Issued by InvestorSoup.com 4 Nov 2009 12:40 GMT
... Trading Outlook for Novavax Inc. Issued by InvestorSoup.com DALLAS, Nov. 4, 2009 ... should be of particular interest to other biotechnology companies: Novartis AG Get our alerts BEFORE ... www.twitter.com/investorsoup Novavax Inc. (NVAX) is a clinical-stage biopharmaceutical company focused on creating differentiated, value-added vaccines ...
- Novavax seasonal flu vaccine meets study goal 2 Nov 2009 15:13 GMT
... Novavax seasonal flu vaccine meets study goal Biotechnology company Novavax Inc. said Monday its seasonal ... met key goals in a midstage clinical trial. The company said it presented the results ...
- Novavax's season flu vaccine candidate meets key goals in midstage study 2 Nov 2009 15:36 GMT
... ROCKVILLE, Md. (AP) - Biotechnology company Novavax Inc. said Monday its seasonal flu vaccine candidate ... met key goals in a midstage clinical trial. The company said it presented the results ...
- Novavax Reports Positive Data For VLP Vaccine Candidate In Second Phase II Study 3 Nov 2009 09:33 GMT
... Novavax Reports Positive Data For VLP Vaccine Candidate In Second Phase II Study VLP vaccine induces hemagglutinin inhibition antibody responses against all ...
- Novavax Reports Narrower-Than-Expected Q3 Loss of $0.08 Per Share (NVAX) 6 Nov 2009 14:30 GMT
... Novavax Reports Narrower-Than-Expected Q3 Loss of $0.08 Per ... make rapid progress with each of our vaccine development programs which are targeting some of ... in real time. To get a free trial of our trading calls and maximize your ...
Powered by 
These stories are not published by IPD Group, Inc. and these links will take you to other websites. Some of these websites require their own registration to read their stories.
<<< Please read the disclaimer for more details.>>> | |
Healthcare Industry Today
|
a digital news provider
bbc.co.uk:
healthday.com:
reuters.com: